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The inhibitory effect of supraphysiological iodide concentrations on thyroid hormone synthesis (Wolff–Chaikoff effect) and on thyrocyte
proliferation is largely known as iodine autoregulation. However, the molecular mechanisms by which iodide modulates thyroid function remain
unclear. In this paper, we analyze the transcriptome profile of the rat follicular cell lineage PCCl3 under untreated and treated conditions with
10−3 M sodium iodide (NaI). Serial analysis of gene expression (SAGE) revealed 84 transcripts differentially expressed in response to iodide
(p≤0.001). We also showed that iodide excess inhibits the expression of essential genes for thyroid differentiation: Tshr, Nis, Tg, and Tpo.
Relative expression of 14 of 20 transcripts selected by SAGE was confirmed by real-time PCR. Considering the key role of iodide organification
in thyroid physiology, we also observed that both the oxidized form of iodide and iodide per se are responsible for gene expression modulation in
response to iodide excess.
© 2008 Elsevier Inc. All rights reserved.Keywords: Iodine; Iodine excess; Autoregulation; Thyroid; PCCl3 lineage; Thyroid differentiation; Transcriptome; Differential gene expression; SAGE; MethimazoleIodine is the main component of T3 and T4 thyroid hormones
and is one of the most important regulators of thyroid function.
Iodine is absorbed by the gastrointestinal tract as iodide and
transported via the blood plasma to the thyroid cells, where it is
actively transported across the basement membrane by the so-
dium iodide symporter (NIS) [1,2]. Iodide is then oxidized by
hydrogen peroxide (H2O2) in a reaction catalyzed by thyroid
peroxidase (TPO) and converted to an active intermediate, which
is incorporated into tyrosyl residues in thyroglobulin (TG)
molecules. Thyroid hormones are formed by the coupling of io-
dotyrosine residues and are released into the bloodstream in
response to pituitary thyrotropin (TSH) stimulation [3].
The regulation of the thyroid function by iodide has been
extensively studied for several decades and is known as iodine
autoregulation [4,5]. It was first reported by Morton [6], who
observed that large amounts of iodide lead to a reduction in iodide
transport into the follicular cell and the blockage of hormone
synthesis—the Wolff–Chaikoff effect [7]. The autoregulatory⁎ Corresponding author. Fax: +55 11 3091 7402.
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doi:10.1016/j.ygeno.2007.12.009mechanism triggered by supraphysiological concentrations of
iodide also inhibits thyroid cell proliferation both in vivo and in
vitro [8–12].
Various aspects of thyroid function have been shown to be
modulated by high iodide treatment, such as iodide transport and
cAMP formation in response to TSH and H2O2 generation.
However, little is known about the gene networks modulated by a
high dose of iodide, which could be involved in those responses.
Thus, identification of all transcripts whose expression is altered
in this situation would provide important information on the
thyroid molecular autoregulatory mechanism. High-throughput
methods for gene expression analysis, like DNAmicroarrays [13]
and serial analysis of gene expression (SAGE) [14] are powerful
tools for large-scale transcriptome studies. Both techniques are
very useful to characterize gene expression patterns under mul-
tiple experimental conditions. However, microarray-based ana-
lysis has some limitations regarding quantification [15,16].
SAGE, on the other hand, generates simultaneous quantitative
and qualitative analysis of thousands of genes [17].
In vitro experimental models have been very useful to in-
vestigate the mechanisms involved in thyroid differentiation
Fig. 1. PCCl3 cell proliferation in response to high iodide treatment. PCCl3 cell
proliferation was measured by (A) cell counting and (B) MTTassay. Columns in
the graph represent mean and SD values for two independent reactions
performed in triplicate. There was significant modulation of gene expression as
compared with the control (⁎p≤0.05).
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rat follicular cell line FRTL-5 [18] is the most frequently used
system, but the PCCl3 cell line [19] also maintains the main
characteristics of differentiated follicular thyroid cells, such as
dependence on TSH for growth and function, Tg and Tpo gene
expression, and iodine uptake. However, there are some specula-
tions about the capacity of these two cell systems to oxidize iodide
and the role of the oxidized form in iodide-induced responses.
We used SAGE to perform a differential gene expression
profile of the rat thyroid cell lineage PCCl3 under high iodide
treatment and also to evaluate the modulation of the thyroid
differentiation genes Tshr (thyroid stimulating hormone recep-
tor), Nis (sodium iodide symporter), Tg (thyroglobulin), and
Tpo (thyroid peroxidase) in response to iodide excess. The
PCCl3 cells were also used to analyze the effect of iodide excess
on growth and the role of iodine oxidation in the modulation of
transcripts identified by SAGE.
Results
Effect of high iodide concentration on cell proliferation
The effect of a high iodide dose on PCCl3 cell proliferation
was analyzed by cell counting and 3-(4.5-dimethylthiazol-2-yl)-
2.5-diphenyltetrazolium bromide (MTT) assay. A reduction in
cell proliferation was observed after 24 h of treatment
(approximately 20%, by MTT assay) and after 48 h of iodide
treatment (approximately 50% by cell counting and 40% by
MTT assay) (Fig. 1).
Comparative analysis of SAGE libraries
To perform a differential gene expression profile of the thy-
roid cell in response to treatment with a high dose of iodide we
constructed two PCCl3 SAGE libraries: one library, called
library 1, from untreated PCCl3 cells and the other library,
called library 2, from PCCl3 cells treated with 10−3 M sodium
iodide (NaI). A total of 48,247 tags were sequenced for both
libraries (21,229 for library 1 and 27,018 tags for library 2).
From these tags, 9966 and 11,481 distinctive tags were iden-
tified for library 1 and for library 2, respectively. These data
have been deposited into the NCBI Gene Expression Omnibus
(GEO; http://www.ncbi.nlm.nih.gov/geo/) and are accessible
through GEO Series Accession No. GSE7174.
The 50 most frequent tags found in the SAGE libraries are
listed in Table 1. A comparative analysis with other thyroid
SAGE libraries shows 15 genes that have been previously
described in mouse and human thyroid transcriptomes [20,21].
In addition, 17 genes for ribosomal proteins were identified,
including ribosomal protein L19, which was not modulated by
iodide treatment and was used in this study as a reference gene
in the quantitative real-time PCR analysis. Six transcripts were
aligned in genomic sequences; however, these transcripts had
no similarity with known transcripts. Although these more
abundant tags did not show any modulation following the
treatment, comparative analysis of tag abundance between li-
braries 1 and 2 using Monte Carlo simulations allowed us toidentify 63 downregulated transcripts and 21 upregulated
transcripts (Table 2) in response to iodide (p≤0.001). Con-
sidering the relevant role of differentiation genes in thyroid
function, the differential expression patterns of tags that cor-
respond to Tshr, Nis, Tg, and Tpo were analyzed separately and
did not follow the parameters stipulated above. This analysis
revealed a downregulatory effect of iodide on thyroid differ-
entiation genes, with the exception of Tpo, since the small
number of tags obtained prevented the analysis of its differential
expression (Table 3).
Biological process of transcripts identified by SAGE
The functional annotation of highly expressed genes iden-
tified in PCCl3 cells, as well as the genes that were highly
modulated by iodide treatment, as identified by SAGE, was
assigned by Gene Ontology (GO). As shown in Table 1, among
the highly expressed genes in PCCl3 cells, 23 (46%) transcripts
were classified in a protein metabolism category (including
biosynthesis, folding, and assembly of proteins). The biological
Table 1
List of 50 most abundant transcripts detected in SAGE libraries for PCCl3 untreated (1) and PCCl3 iodide-treated cells (2)
Tag Tag count a
(1/2)
Description Accession No. Biological process b
ATAACACATA 1464/1706 Protein tyrosine phosphatase nonreceptor type 1 (Ptpn1) NM_012637 Cytoskeleton organization
and biogenesis
ATACTGACAC 998/993 Genome match — —
GATCAGTCAT 511/507 Ribosomal protein L19 (Rpl19) NM_031103 Protein biosynthesis
TCAGGCTGCC 473/383 Ferritin heavy polypeptide 1 (Fth1) c NM_012848 Cell proliferation/iron ion
homeostasis
GATGCCCCCC 383/357 Genome match — —
AATCGGAGGC 317/183 Olfactory receptor 666 (predicted) (lr666_predicted) NM_001000924 Signal transduction
CTAGTCTTTG 266/360 Ribosomal protein S29 (Rps29) c NM_012876 Protein biosynthesis
AGCCATCCCT 244/255 Genome match — —
ACGTCTCAAA 242/299 Tubulin α1 (Tuba1) NM_022298 Microtubule-based
process
TGACTATTAA 190/205 cDNA clone MGC:125176 IMAGE:7371608 XM_001071627 Protein biosynthesis
GGATTTGGCC 167/120 Ribosomal protein large P2 (Rplp2) c NM_001030021 Protein biosynthesis
TCCAATAAAG 160/192 Ribosomal protein largeP1 (Rplp1) NM_001007604 Protein biosynthesis
GCACGGGAAT 160/183 Ribosomal protein L17 (Rpl17) NM_201415 Protein biosynthesis
GGTAGCCACT 138/77 Similar to ribosomal protein S27a (LOC683631) c NM_031113 Unspecified
GGCAAGCCCC 136/140 Ribosomal protein L10A (Rpl10a) c NM_031065 Protein biosynthesis
AGGAGGCTAC 134/127 Ribosomal protein L14 (Rpl14) NM_022949 Protein biosynthesis
GGATTCGGTC 122/170 Acidic ribosomal phosphoprotein P0 (Arbp) NM_022402 Protein biosynthesis
TGGGTTGTCT 122/94 Transcribed locus, strongly similar to XP_620353.1 (predicted): similar
to tumor protein, translationally controlled 1 (Mus musculus) c
— Unspecified
AGCGATTCAA 122/136 Genome match — —
TAGGTACAGG 117/157 Genome mach — —
TAGGTACAGG 117/157 Genome match — —
CCAAGGAAAA 115/125 Lactate dehydrogenase A (Ldha) NM_017025 Lactate dehydrogenase
activity
TAGGCCACAC 108/61 ATP synthase H+ transporting mitochondrial F1 complex β polypeptide (Atp5b) c NM_134364 Ion transport
ATGAAATCAA 101/157 Ribosomal protein S4 X-linked (Rps4x) c NM_001007600 Protein biosynthesis
CGGAAGGCGG 101/125 Ribosomal protein L36 (Rpl36) NM_022504 Protein biosynthesis
GAAAAATAAA 98/172 Aspartyl tRNA synthetase (Dars) NM_053799.1 Protein complex assembly
GGAGGGGAAG 98/172 Transcribed locus — Unspecified
GAAGCAGGAC 96/72 Cofilin 1 (Cfl1) NM_017147 Cell motility
AGGCAGACAG 96/79 Eukaryotic translation elongation factor 1 α1 (Eef1a1) c NM_175838 Protein biosynthesis
CCCAGTTTTC 91/86 Ribosomal protein L26 (Rpl26) XM_213346 Protein biosynthesis
CCTCAGCCAG 87/72 Similar to 40S ribosomal protein S3 (RGD1560831_predicted) XM_575143 Unspecified
ATGCAACTAC 84/157 Similar to cytochrome c oxidase polypeptide VIb (cytochrome c oxidase
subunit AED) (RGD1565270_predicted)
XM_001071713 Unspecified
AAGAGAAGCT 84/85 Similar to 60S ribosomal protein L35 (LOC686074) XM_001066433 Unspecified
CGCTGGTTCC 82/53 Similar to 60S ribosomal protein L11 (predicted) (RGD1560231_predicted) c NM_001025739 Protein biosynthesis
GATTCCGTGA 77/64 Ribosomal protein L37 (Rpl37) c NM_031106 Protein biosynthesis
TTGTTAGTGC 77/74 Malate dehydrogenase 1, NAD (soluble) (Mdh1) NM_033235 Malate dehydrogenase
activity
GAAATATGTG 77/112 ATP synthase, H+ transporting, mitochondrial F0 complex, subunit c
(subunit 9) isoform 3 (Atp5g3)
NM_053756 Hydrogen transporter
TCTTGCCAGT 75/66 Eukaryotic translation elongation factor 1γ (Eef1g) XM_574616 Protein biosynthesis
CTGCCTAGCG 73/38 Ribosomal protein L32 (Rpl32) c NM_013226 Protein biosynthesis
GCATATTGAA 65/105 Cytochrome c oxidase subunit VIIb (Cox7b) NM_182819 Electron transport
GATGTGGCTG 65/79 Similar to eukaryotic translation elongation factor 1 β2 (LOC361750) AY321330.1 Unspecified
AAGAGGCAAG 65/42 Ribosomal protein S15a (Rps15a) NM_053982 Protein biosynthesis
GATGCAGCCA 63/31 Actin, β (Actb) NM_031144 Regulation of actin
cytoskeleton
GAGTGGACTC 63/44 CD63 antigen (Cd63) NM_017125.2 Positive regulation of
endocytosis
GTGAAGGCGG 63/48 Ribosomal protein S3a (Rps3a) c NM_017153 Protein biosynthesis
GAGCGTTTTG 63/51 Peptidylprolyl isomerase A (Ppia) NM_017101 Protein folding
GCCCGAGCCA 61/44 Ribosomal protein L13 (Rpl13) NM_031101 Protein biosynthesis
CCAGAACAGA 61/99 Ribosomal protein L30 (Rpl30) c NM_022699 Protein biosynthesis
TTCAATAATA 61/77 Similar to ribosomal protein L10 (RGD1561736_predicted) c XM_575130 Unspecified
a SAGE tag counts after normalization to 50,000 tags.
b Biological process assigned by Gene Ontology.
c Transcripts highly expressed also in human and mouse SAGE libraries [20,21].
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Table 2
Significantly modulated transcripts detected by comparative analysis of SAGE libraries for PCCl3 untreated cells and PCCl3 iodide treated cells
Tag Tag
count a
Description Accession No. Biological process
1 b 2 b
Downregulated transcripts
GTGCTTTGTC 21 1 Dipeptidylpeptidase 7 (Dpp7) NM_031973.1 Proteolysis
AACTGACACT 16 0 Genome match — —
ACTGCACACG 16 0 Clathrin heavy polypeptide (Hc) (Cltc) NM_019299.1 Intracellular protein transport
CCACTAACAC 16 1 Aldo-keto reductase family 1 member B4 (Ark1b4) NM_012498 Carbohydrate metabolism
TTTCATTGCT 16 1 Low-density lipoprotein receptor-related protein 8 apolipoprotein
E receptor (predicted) (Lrp8_predicted)
XM_342877 Positive regulation of
protein kinase activity
GACTTCCAGG 14 0 Interferon regulatory factor 3 (Irf3) NM_001006969 Transcription/response to virus
TTTTATTTTG 14 0 Transcribed locus — Unspecified
AAGGGTCCCC 14 1 Phosphoribosyl pyrophosphate synthetase-associated protein 1 (Prpsap1) NM_022545.2 Nucleotide biosynthesis
AGATAAGCTG 14 1 Protein phosphatase 2, regulatory subunit B (B56), α isoform
(predicted) (Ppp2r5a_predicted)
XM_232413 Unspecified
CAAGGGACAA 14 1 Cyclic nucleotide phosphodiesterase 1 (Cnp1) NM_012809 Cytoskeleton organization
and biogenesis
GAAACAGAAA 14 1 Nucleobindin 1 (Nucb1) NM_053463 Structural constituent of the
bone
GGGAAAGCCT 14 1 ERM binding phosphoprotein (Slc9a3r1) NM_021594 Signal transduction
TGTATTATTT 14 1 Sec61 β subunit (predicted) (Sec61b_predicted) XM_216400 Intracellular protein transport
CAAGGGACAA 14 1 Cyclic nucleotide phosphodiesterase 1 (Cnp1) NM_012809 Cytoskeleton organization
AAATGCAGTT 11 0 Myosin IC (Myo1c) NM_012983 Cytoskeleton organization
AGGGAGTGGG 11 0 Similar to mitochondrial ribosomal protein S11 (RGD1559901_predicted) XM_574478 Unspecified
GAGGGTGCTC 11 0 Hypothetical protein RDA279 (Rda279) XM_001070821 Unspecified
GGAAGCTCTG 11 0 Envoplakin (predicted) (Evpl_predicted) XM_221129 Epidermis development
GGGGGAGATT 11 0 Genome match — —
GGTACCGCGG 11 0 LOC301123 RE70703p-like (Ndufa11) NM_212517 Unspecified
GGTCTAATTT 11 0 Chaperonin containing TCP1 subunit 2 (β) (Cct2) NM_001005905 Protein folding
GTTGCTTTTA 11 0 Acidic (leucine rich) nuclear phosphoprotein 32 family, member
E (predicted) (Anp32e)
NM_001013200 Phosphatase regulator activity
TATCCAAGTC 11 0 Ubiquinol cytochrome c reductase core protein 2 (Uqcrc2) NM_001006970 Electron transport
TCACAACCAC 11 0 Cytochrome b5 outer mitochondrial membrane isoform (Cyb5b) NM_030586 Electron transport
TTCTGTCCTA 11 0 Similar to RNA polymerase 1-3 (MGC112727) NM_001037787 Unspecified
TTGTGAAATC 11 0 Protein phosphatase 3 regulatory subunit B α isoform (Ppp3r1) NM_017309 Defense response/glycogen
metabolism
CATTCAGAGT 11 1 Transcribed locus — —
AATTCAATTA 11 1 Similar to Eif4g1 protein (RGD1562125_predicted) XM_573072 Unspecified
ATACTACACT 11 1 Genome match — —
TATAATCTGT 11 1 Matrin 3 (Matr3) NM_019149 Transcription
TCGTTTTTTA 11 1 Thymoma viral proto-oncogene 1 (Akt1) NM_033230 Signal transduction
TGCGTTGTTT 11 1 Angiomotin like 2 (Amotl2) XM_001068539 Angiogenesis
ACCCCACTTC 9 0 Similar to eukaryotic translation initiation factor 1A,
Y-linked (RGD1560198_predicted)
XM_217622 Unspecified
ACCCTGCAGT 9 0 Sin3-associated polypeptide, 18 kDa (predicted) (Sap18) NM_001033685 Regulation of transcription from
RNA polymerase II promoter
ACTCAATTCA 9 0 Glycerol-3-phosphate dehydrogenase 1 (soluble) (Gpd1) NM_022215 Carbohydrate metabolic process
AGTCCAAGTA 9 0 Similar to TR4 orphan receptor-associated protein TRA16 (LOC361128) NM_001047104 Unspecified
ATAAAGTAAC 9 0 Serine/threonine kinase receptor-associated protein (Strap) NM_001011969 Signal transduction
ATACTTACAC 9 0 Genome match — —
CAGGTAGCAA 9 0 Similar to 8D6 antigen (predicted) (LOC688345) NM_001014201 Unspecified
CCTTACACTT 9 0 Genome match — —
CTACCGCACT 9 0 Cullin 1 (predicted) (Cul1_predicted) XM_342679
CTGGCTGACT 9 0 Similar to proline and glutamic acid-rich nuclear protein; modulator
of nongenomic activity of estrogen receptor (predicted)
NM_001024270 Unspecified
CTGGTGTTAA 9 0 Similar to DnaJ (Hsp40) homolog, subfamily B, member
6 (predicted) (LOC687325)
XM_001077995 Unspecified
GAGACCCTCA 9 0 Opioid receptor, σ1 (Oprs1) NM_030996 Nervous system development
GCCCCGGTGC 9 0 Similar to yippee-like 3 (RGD1564579_predicted) XM_215057 Unspecified
GGCTGTTTCT 9 0 Flap structure-specific endonuclease 1 (Fen1) NM_053430 DNA repair
TATAGATTTC 9 0 Peroxisomal biogenesis factor 14 (Pex14) NM_172063 Peroxisome organization
and biogenesis
TCATTTAAAC 9 0 Potassium channel regulator 1 (LOC245960) NM_139101 Potassium channel
regulator activity
(continued on next page)
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Table 2 (continued)
Tag Tag
count a
Description Accession No. Biological process
1 b 2 b
Downregulated transcripts
TCTGTGTATA 9 0 Angiopoietin-like 2 (Angptl2) NM_199115 Multicellular organismal
development
TCTTCTGCTC 9 0 Catenin src (predicted) (Ctnnd1_predicted) XM_242062 Cell adhesion
TTCCAGACCC 9 0 Ribophorin II (Rpn2) NM_031698 Protein modification
TTCCAGCAGG 9 0 Similar to RIKEN cDNA 3110052N05 (predicted) (RGD1308579) NM_001014151 Unspecified
ACTCTCAGCC 37 5 Genome match — —
TTCTGGCTGC 21 3 Ubiquinol-cytochrome c reductase core protein I (Uqcrc1) NM_001004250 Electron transport
GAGTGATTAT 18 3 Zinc finger protein 162 (Zfp162) NM_058210 Induction of apoptosis
TCATAGAAAC 16 3 Chaperonin subunit 5 (ɛ) (Cct5) NM_001004078 Protein folding
TCATTGAACT 25 5 Malate dehydrogenase 2, NAD (mitochondrial) (Mdh2) NM_031151 Malate dehydrogenase activity
GAAGGTGGGG 21 5 Granulin (Grn) NM_017113 Positive regulation of
cell growth
CCTCACTTTA 25 7 Ubiquinol-cytochrome c reductase binding protein (predicted) (Uqcrb_predicted) XM_343225 Electron transport
ATCCGAAAAA 18 5 Ribosomal protein L28 (Rpl28) NM_022697 Protein biosynthesis
GATGTGGTAC 21 7 Peptidylprolyl isomerase B (Ppib) Nuclear transport
GGCCGCGTTC 21 7 Ribosomal protein S17 (Rps17) NM_022536 Protein biosynthesis
TTCCAGCTGC 58 27 Phosphoglycerate mutase 1 (Pgam1) NM_053290 Glycolysis
Upregulated transcripts
ACTGAAGCAA 0 19 Scavenger receptor class B member 1 (Scarb1) NM_031541 Regulation of phagocytosis
CTGGGGCATC 0 18 Genome match — —
TGAGACAAGG 0 14 Cell division cycle 42 homolog (Saccharomyces cerevisiae) (Cdc42) NM_171994 Signal transduction
TGGTTTAGGG 0 14 Riboflavin kinase (Rfk) NM_001014106 Riboflavin biosynthetic process
GGGATTGCTG 2 25 Similar to 2310044H10Rik protein (MGC93975) NM_001004221 Unspecified
GAGGAAAGAA 0 12 Cyb561d2 cytochrome b561 domain containing 2 (Cyb561d2) NM_001007753 Iron ion homeostasis
GGCAGGGATC 0 12 Protein phosphatase 1 regulatory (inhibitor) subunit 14B (Ppp1r14b) NM_172045 Signal transduction
GTGTCAGACT 0 12 Transcribed locus — Protein biosynthesis
TAGATGACTT 0 12 Similar to pyruvate kinase (EC2.7.1.40) isozyme M2-rat (RGD1561681_predicted) XM_573941 Unspecified
GAAGCTAATA 0 11 Mitogen-activated protein kinase kinase 3 (Map2k3) XM_239239 Signal transduction
CACCAAAGGC 0 11 S100 calcium-binding protein A1 (S100a1) NM_001007636 Calcium ion homeostasis
ACCGATCCCA 0 11 Glutathione peroxidase 2 (Gpx2) NM_183403 Glutathione metabolism
AAGAAACTAT 0 11 Superkiller viralicidic activity 2-like (Skiv2l) NM_213559 Cell growth and division
GAAGCTAATA 0 11 Mitogen-activated protein kinase kinase 3 (predicted) (Map2k3) XM_239239 Signal transduction
CTAACTAGTT 2 18 Genome match — —
GACTATAAGA 2 18 Hypothetical LOC361911 Unspecified
TGAACACACA 2 18 Myosin binding protein H (Mybph) NM_031813 Cell adhesion
TGTATAATCA 2 18 Myosin light chain, regulatory B (Mrlcb) NM_017343
GATTGTCTTG 7 35 FK506 binding protein 3 (predicted) (Fkbp6_predicted) XM_222082 Protein folding/cell cycle
ATCAGTGTCC 9 37 Transcribed locus strongly similar to NP081234.1 hypothetical protein LOC380773
(Mus musculus)
— Unspecified
GCGGCGGATG 11 40 Lectin galactose-binding soluble 1 NM_019904.1 Cell proliferation
a SAGE tag counts after normalization to 50,000 tags (p≤0.0001).
b 1, library 1 (untreated cells); 2, library 2 (iodide-treated cells).
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their similarity to proteins of other organisms.
The annotation of 84 transcripts modulated by iodide (Table 2)
allowed us to identify a number of processes that are altered by
iodide administration. Eleven transcripts (13%) are related to pro-
tein metabolism, including protein biosynthesis, folding, and
intracellular transport, and 7 (8.3%) are related to the signal trans-
duction category. Approximately 50% of the transcripts are related
to the categories of electron transport, regulation of cell growth, ion
homeostasis, cytoskeleton organization, transcription, and cell
adhesion. The biological function of 19 (22.6%) transcripts mo-
dulated by iodide has not yet been determined. To have an over-
view of the main biological process categories inferred from theGO that are being modulated by iodide, we analyzed the 63
downregulated genes and the 21 upregulated genes using the Fatigo
bioinformatic tool (Fig. 2). This analysis showed results similar to
those described above; most of the modulated genes belong to the
following categories: proteinmetabolic process, which includes the
chemical reactions and pathways involving a specific protein,
rather than proteins in general; cellular macromolecule metabolic
process, defined as the chemical reactions and pathways carried out
by individual cells involving macromolecules, i.e., large molecules
including proteins, nucleic acids, and carbohydrates; transport,
which involves the direct movement of substances into, out
of, within, or between cells; and signal transduction, i.e., the
cascade of processes by which a signal interacts with a receptor,
Table 3
Thyroid differentiation genes identified by SAGE analysis for PCCl3 untreated
and PCCl3 iodide-treated cells
Tag Tag
count a
Gene name Accession
No.
1 b 2 b
CGTGGAGGAT 7 1 Thyroid stimulating
hormone receptor
NM_012888
CCCAGCTTTT 25 12 Slc5a5 solute carrier family 5
(sodium iodide symporter) member 5
NM_052983
AGTTCTCACA 40 22 Thyroglobulin NM_030988
TTTTTCCACA 3 0 Thyroid peroxidase NM_019353
a SAGE tag counts after normalization to 50,000 tags (p≤0.0001).
b 1, library 1 (untreated cells); 2, library 2 (iodide-treated cells).
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or of another downstream target, thus ultimately effecting a
change in the functioning of the cell.
Validation of SAGE data
The validation of SAGE data by quantitative real-time PCR
was performed for 14 iodide-modulated transcripts. As shown in
Fig. 3, quantitative real-time PCR analysis confirmed the re-
duction in the mRNA expression in response to iodide for 5
downregulated transcripts: Ark1b4 (aldo-keto reductase family
1 member 4) (0.85±0.02 vs. 0.73±0.07), Irf3 (interferon regu-
latory factor 3) (1.27±0.28 vs. 0.70±0.07),Myo1d (myosin ID)
(2.15±0.21 vs. 1.27±0.22), Prpsap1 (phosphoribosyl pyropho-
sphate synthetase-associated protein 1) (9.00±1.00 vs. 6.65±
0.32), and Sec61b_predicted (Sec61 βsubunit predicted) (0.70±
0.002 vs. 0.40±0.006). The analysis also confirmed the mo-
dulation of 5 upregulated transcripts in response to iodide:Fig. 2. Functional classification of the expressed sequence tags obtained from SAGE
iodide. This analysis was carried out using the Fatigo bioinformatics tool found in th
represents the percentage of downregulated (black bars) and upregulated genes (gray
(y axis). Note: Some of these genes are assigned to more than one functional categoCyb561d2 (cytochrome b561 domain-containing 2) (0.45±0.01
vs. 0.68±0.09), Rfk (riboflavin kinase) (3.53±0.11 vs. 4.35±
0.55), Lgals1 (lectin galactose-binding soluble 1) (6.12±0.47
vs. 7.66±0.51), Ppp1r14b (protein phosphatase 1 regulatory
inhibitor subunit 14B) (2.93±0.21 vs. 4.44±0.99), and Scarb1
(scavenger receptor class B member 1) (0.81±0.01 vs. 1.10±
0.18) (Fig. 4). Also, quantitative real-time PCR analysis
confirmed the SAGE data showing a downregulatory effect of
iodide on thyroid differentiation genes: Tshr (11.6±1.33 vs.
2.06±0.18), Nis (21.8±1.66 vs. 5.29±0.24), Tg (189.0±22.0
vs. 55.0±3.55), and Tpo (0.94±0.08 vs. 0.68±0.03) (Fig. 5).
Next, we analyzed the effect of methimazole (MMI) treat-
ment on the transcriptional modulation of genes by iodide. MMI
is a drug that blocks the reactions catalyzed by TPO, and this
property has been used to analyze the role of oxidized io-
dide on transcriptional modulation induced by iodide excess
[22]. The concomitant treatment of PCCl3 cells with MMI
(10−4 M) and NaI (10−3 M) increased mRNA expression le-
vels of modulated genes validated by a real-time PCR, Ark1b4,
Irf3, Myo1d, Rfk, and Scarb1, at higher levels than in untreated
cells (Figs. 3 and 4). However, for one of five validated down-
regulated transcripts (Sec61_predicted), and for one of five
validated upregulated transcripts (Cyb561d2), the treatment with
MMI restored gene expression to the level found in the control
cells. For Prpsap, Lgals1, and Ppp1r14b, the MMI treatment
modulated their expression to the levels observed in iodide-
treated cells. Three genes for which modulation by iodide was
not confirmed by real-time PCR were also upregulated by MMI
treatment: Dpp7 (dipeptidylpeptidase 7), Cdc42 (cell division
cycle 42 homolog Saccharomyces cerevisiae), MGC93975 (si-
milar to 2310044H10Rik protein and S100A1). Our analysis
also showed that the downregulation of the thyroid differentiationlibraries of untreated PCCl3 cells and of PCC13 cells treated with a high dose of
e Babelomics Web site: http://babelomics.bioinfo.cipf.es/index.html. The x axis
bars) modulated by iodide and classified according to their biological function
ry.
Fig. 3. Real-time PCR confirmation of SAGE data. mRNA expression levels of downregulated genes identified by SAGE analysis in PCCl3 cells (control, black bars),
PCCl3 cells treated with 10−3 M NaI, and PCCl3 cells treated with 10−3 M NaI plus 10−4 M methimazole (MMI) after 24 h of treatment. Gene expression levels were
normalized to Rpl19 gene expression. Columns in the graph represent mean and SD values of two independent reactions performed in triplicate. (⁎) There was
significant modulation of gene expression compared with the control. (⁎⁎) There was significant modulation of gene expression compared with control and iodide-
treated cells (p≤0.05).
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whereas the downregulatory effect of iodide on Nis mRNA
expression was not altered by MMI treatment (Fig. 5).
Discussion
In this report we have shown the effect of high iodide con-
centration on thyroid follicular cell gene expression patterns.
The SAGE technique allowed us to identify all differentially
expressed transcripts in response to iodide treatment and toFig. 4. Real-time PCR confirmation of SAGE data. mRNA expression levels of upre
PCCl3 cells treated with 10−3 M NaI, and PCCl3 cells treated with 10−3 M NaI plus 1
Rpl19 gene expression. Columns in the graph represent mean and SD values of two in
of gene expression compared with the control. (⁎⁎) There was significant modulatioprovide a profile of genes expressed in the thyroid follicular cell
lineage PCCl3. The large quantity of housekeeping genes
for ribosomal proteins present in both libraries (Table 1) is in
agreement with the human thyroid SAGE library and is con-
sistent with the situation already reported for SAGE libraries of
mouse thyroid, mouse uterus, human muscle cells and nasal
mucosa, and adrenocortical tumors [23–27,21,20]. Also, the
presence of ferritin as one of the most highly expressed mes-
sengers in the PCCl3 cells (Table 1) has already been described
in human thyroid and cervical tissues [25,20].gulated genes identified by SAGE analysis in PCCl3 cells (control, black bars),
0−4 M MMI, after 24 h of treatment. Gene expression levels were normalized to
dependent reactions performed in triplicate. (⁎) There was significant modulation
n of gene expression compared with control and iodide-treated cells (p≤0.05).
Fig. 5. Real-time PCR analysis of thyroid differentiation genes. Fold change of mRNA expression levels of Tshr, Nis, Tg, and Tpo in PCCl3 cells (control, black bars),
PCCl3 cells treated with 10−3 M NaI, and PCCl3 cells treated with 10−3 M NaI plus 10−4 M MMI, after 24 h of treatment. Gene expression levels were normalized to
Rpl19 gene expression. Columns in the graph represent mean and SD values of two independent reactions performed in triplicate. (⁎) There was significant modulation
of gene expression compared with the control. (⁎⁎) There was significant modulation of gene expression compared with control and iodide-treated cells (p≤0.05).
363S.G. Leoni et al. / Genomics 91 (2008) 356–366The most highly downregulated and upregulated genes,
Dpp7 and Scarb1, respectively, have never been related to thy-
roid function. Dipeptidylpeptidase 7, also called quiescent di-
peptidase, is located in the lysosome and plays an important role
in the degradation of some oligopeptides [28]. Scarb1, present
only in the iodine library, is involved in phagocytosis, as it binds
to phosphatidylserine on the surface of apoptotic cells [29].
Several iodine-modulated transcripts are related to protein me-
tabolism, protein biosynthesis, folding, and transport. Among
them are the downregulated genes Cct2 (chaperonin containing
TCP1, subunit 2β) and Cct5 (chaperonin subunit 5ɛ) (Table 2),
which are essential for protein folding in the eukaryotic cell [30].
These data provide a new source of genes, not yet described in
thyroid, which could be involved in iodine autoregulatory
metabolism and deserve further investigation.
Of the TSH-inducible thyroid activities, H2O2 production is a
key process for hormone synthesis [31]. Therefore, protection
against oxidative stress is essential for normal thyroid functioning
and is performed by selenium-containing proteins, among other
factors [32]. Several selenoproteins participate in antioxidant
defenses, including glutathione peroxidases, which are involved in
H2O2 degradation and play an important role in iodination process
control [33,34]. Using SAGE, we found that iodide excess leads to
an upregulation in mRNA expression of Gpx2 (glutathione
peroxidase 2) (Table 2), previously described as gastrointestinal
selenoprotein [35]. Interestingly, we found the mRNA for another
selenoprotein called Txn1 (thioredoxin 1), which is present at high
levels in both libraries and undergoes a 1.5-fold upregulation by
iodine (data not shown). These data suggest that excess iodine
could be promoting a decrease in H2O2 availability and thatGpx2and Txn1 could be involved in this effect. However, considering
that TPO activity is preserved in PCCl3 cells, the increased
expression ofGpx2 and Txn1 can be a response to oxidative stress.
Considering the relevant role of autoregulation in thyroid cell
growth, iodide treatment of the PCCl3 cell has led to a 20 and 50%
reduction in proliferation after 24 and 48 h, respectively (Fig. 1).
Using SAGE, we found several genes involved in both the inhi-
bition and the induction of cell growth. Of these genes, Lgals1was
highly induced by the treatment. Many functions have been attri-
buted to Lgals1, including mediating cell-to-cell and cell-to-matrix
adhesion, inducing Tcell apoptosis, and inhibiting cell proliferation
[36]. However, the role of Lgals1 in thyroid is not well established.
We also foundGrn (granulin), whose mRNA expression decreased
in response to the treatment, and interestingly, it acts as a positive
regulator of epithelial cell proliferation [37].
Some transcripts that play a role in proliferative pathway
signal transduction, such as Akt-1 (thymoma viral proto-
oncogene 1), Cdc42, Ppp1r14b, and Mapk3 (mitogen-activated
protein kinase 3) are also modulated by iodide. These genes
have a well-established biological function: AKT-1 is a central
signaling molecule in the phosphatidyl inositol 3-kinase
pathway [38], and CDC42 is a member of the Rho family of
small GTPases and plays a pivotal role in the control of many
cellular functions [39]. The protein encoded by the Ppp1r14b
gene is known by its phosphatase inhibitor activity [40] and
MAPK3 is a component of the Ras/Mapk pathway, one of the
most important thyroid growth and function regulators [41].
To understand the modulation of genes related to thyroid
differentiation we analyzed the effect of iodide on Tshr, Nis, Tg,
and Tpo expression. We detected a reduction of more than 50% in
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titative analysis, with the exception of Tpo, for which lower
modulation was observed. Tpowas detected at a very low level in
the SAGE library as has already been described for human thyroid
[20]. As TSH is considered the main thyrocyte function regulator,
the significant downregulation in TshrmRNA levels may account
for the effects of iodide on both cell differentiation and pro-
liferation. These data are consistent with a recent study reporting
that the inhibition of FRTL-5 cell growth in response to iodide is
dependent on Tshr activation [42]. The reduction in Nis mRNA
after iodide treatment had already been observed after 24 h in
Sprague–Dawley rats and after 48 h in FRTL-5 cells [43,44].
Methimazole is a thionamide compound that blocks thyroid
peroxidase activity [45]. In FRTL-5 cells it has been reported that
both cAMP-dependent (activated by TSH) and cAMP-indepen-
dent proliferative pathways (such as those activated by insulin) are
inhibited by MMI [46]. The administration of high iodide
(10−4 M) and MMI (10−4 M) doses has shown that the inhibitory
effect of iodine on cell growth (FRTL-5) is partially prevented by
methimazole [8]. Our study shows that MMI reverses the
inhibitory effect of a high iodide dose on thyroid gene expression.
However, for three of five downregulated validated genes
(Ark1b4, Irf3, and Myo1d) MMI allowed an increase in the
mRNA expression at higher levels than those of control cells. For
two of five upregulated transcripts (Rfk and Scarb1), MMI
increased the RNA expression levels up to those observed in
iodide-treated cells. Three genes for which the iodide effect was
not confirmed by quantitative PCR (Dpp7, Cdc42, and
MGC93975) also had their expression increased by MMI. These
observations suggest that oxidized iodide plays an essential role in
the modulation of some transcripts by iodide excess. However,
this high increase in the mRNA expression could be related to
MMI action as well as to its association with iodide per se. The
effects of MMI on thyroid cells have not been completely elu-
cidated, and to confirm these speculations more knowledge about
MMI mechanisms on follicular cells is necessary. Themodulation
of two upregulated transcripts (Lgals1 and Pp1r14b) by iodide
was not altered byMMI treatment, which suggests a direct role of
iodide per se in this effect. Three transcripts, two downregulated
(Prpsap and Sec61) and one upregulated (Cyb561d2) by iodide,
had their expression restored to control levels after MMI
treatment, suggesting that their modulation is probably due to
oxidized iodide and that MMI is not involved in the mechanisms
controlling the mRNA expression of those genes.
In conclusion, SAGE was satisfactory for generating a global
profile of the PCCl3 cell transcriptome and identify transcripts
that are modulated by iodide. Moreover, SAGE allowed us to
find a high number of tags associated with transcripts that have
not yet been characterized and to find genes not yet related to
thyroid functions, providing potential targets for further studies.
Material and methods
Cell culture
Rat PCCl3 thyroid cells were kindly provided by James Fagin (Cincinnati
University, Cincinnati, OH). They were cultured in Ham's F12 medium
supplemented with 5% calf serum and four hormones: 1 mU/ml bovine TSH(Sigma, St. Louis, MO, USA), 10 μg/ml insulin (Sigma), 5 μg/ml transferrin
(Sigma), and 10 nM hydrocortisone (Sigma). Cells were maintained at 37 °C and
5% CO2 with a change of medium every second day.
Cell proliferation assays
Cells were seeded into six-well plates at a density of 5×104 cells/well. When
the cells reached 50% the medium was replaced by fresh medium supplemented
with the four-hormone preparation and 10−3 M NaI. After 24 and 48 h of
treatment, the number of cells was counted in a hemocytometer and the average
cell number from quadruplicate measurements was determined. For MTT assay,
untreated cells and iodide-treated cells were seeded into 96-well plates (100 μl/
well). After 4 h, MTT (Amresco, Solon, OH, USA) was added to the medium at
a concentration of 0.125 mg/ml. After 3 h, the medium was removed and the
cells were solubilized in 100 μl 0.04 M HCl in isopropanol and the reaction
product was measured by a spectrophotometer at 595 nm.
RNA extraction
Cells were cultured as described above. When the cells reached 50%
confluence the medium was replaced by fresh medium supplemented with the
four-hormone preparation and 10−3 M sodium iodide. After 24 h, untreated
cells and iodide-treated cells were harvested and total RNAwas extracted using
TRIzol reagent (Invitrogen, San Diego, CA, USA) according to the manu-
facturer's instructions. To study the effect of the blockage of iodide oxidization
(by the inhibition of TPO activity) on the transcript modulation by iodide
excess, the PCCl3 cell line was cultured under the same conditions as specified
above, but was treated with 10−3 M sodium iodide plus 10−4 MMMI (Sigma).
Generation of SAGE libraries
SAGE libraries were constructed using the I-SAGE Kit (Invitrogen) based on
the technique developed by Velculesco et al. [50], using 15 μg of total RNA from
untreated PCCl3 cells (library 1) and from iodide-treated PCCl3 cells (library 2),
following the manufacturer's instructions. Briefly, polyadenylated RNA was
isolated using magnetic beads and reverse transcribed to cDNA. The cDNAwas
digested with NlaIII (anchoring enzyme) and the sample was divided into two
equal pools. Each pool was then ligated to linkers, called A and B. The fragments
were released from the magnetic beads by cleavage with BsmF1 (tagging enzyme)
and ligated to form 100-bp ditags (80 bp of linker sequences and 10–12 bp of each
tag). Ditags were amplified by large-scale PCR and the product was digested with
NlaIII, releasing 20- to 24-bp ditags, which were purified by polyacrylamide gel
electrophoresis. The ditags were then self-ligated to form concatemers (a sequence
of at least 20 ditags), which were cloned in the SphI site of the pZErO vector and
transformed in One Shot TOP10 Eletrocomp Escherichia coli. Clones with inserts
ranging from 500 to 1200 bpwere selected byminiprep and sequencedwith the ET
DyeTerminator Cycle Sequencing Kit (GE Healthcare, Little Chalfont, Buck-
inghamshire, UK) using the M13 forward primer for multicapillary sequencer
Mega Bace 1000 (GE Healthcare).
SAGE data processing and bioinformatic analysis
After the clones were sequenced, sequence data were analyzed by SAGE2000
software version 4.12, which identified anchoring enzyme sites and extracted the two
tags flanked by theNlaIII site from the concatemers. After raw data processing, each
library was normalized to a total of 50,000 tags for comparative analysis of fre-
quencies. p values were calculated by the SAGE2000 software using Monte Carlo
simulations [17]. Those transcripts with p≤0.001 showing at least a twofold change
between libraries were considered differentially expressed transcripts. The cDNA
sequences from the UniGene, RefSeq, and dbEST databases and the genome
sequence of Rattus norvegicuswere used to provide transcript identification for each
tag. A minimum of one expressed sequence tag with a known poly(A) tail had to be
identified in the cDNA sequences. Then, the last NlaIII site in the corresponding
sequence was recognized and the presence of the related tag was confirmed.
The functional annotation of each differentially expressed transcript iden-
tified by our tags was assigned following the GO Consortium criteria, the widely
365S.G. Leoni et al. / Genomics 91 (2008) 356–366used bio-ontology [48]. GO represents biological knowledge as a tree (more
precisely as a directed acyclic graph (DAG) in which a node can have more than
one parent). Upper nodes represent more general concepts and as the DAG is
traversed toward deeper levels, the definitions become more and more precise
(i.e., cell cycle → regulation of cell cycle→ positive regulation of cell cycle).
Each GO entry is identified by a term name, which is assigned to one of the three
ontologies: molecular function, cellular component, or biological process. In
this paper we focused our analysis on the biological process ontology, which
describes a biological function to which the gene or gene product actively
contributes. An overview of the main biological process categories that are mo-
dulated by iodide was obtained through Fatigo, a bioinformatic tool found in the
Babelomics Web site: http://babelomics.bioinfo.cipf.es/index.html [49]. Since
the same gene can belong to distinct categories, this tool provides a general
analysis of biological functions altered by the treatment.
Gene expression analysis by real-time quantitative RT-PCR
The cDNAused in this analysis was obtained from 3μg of total RNA,whichwas
reverse-transcribed in a 20-μl reactionwith 200 ng randomprimers (Invitrogen), 10U
RNase inhibitor (Invitrogen), 0.1 mM dNTP (GE Healthcare), and 400 U M-MLV
reverse transcriptase (Invitrogen). The reaction was performed under the following
conditions: 21 °C for 10min, 42°C for 30min, and 99°C for 10min. Fifty nanograms
of cDNA was used in a 20-μl real-time PCR containing 200 nM each primer pair
corresponding to seven significantly downregulated genes (Ark1b4, Dpp7, Irf3,
Myo1d, Ppp2r5a, Prpsap, Sec61) and seven significantly upregulated genes (Cdc42,
Cyb561d2, MGC93975, Rfk, Lgals1, Pp1r14b, Scarb1) selected by SAGE. These
genes were chosen from the highly differentially expressed genes representing dis-
tinctive categories of biological functions. We also constructed primers for the four
genes related with thyroid differentiation: Tshr (thyroid stimulating hormone recep-
tor), Nis (sodium iodide symporter), Tg (thyroglobulin), and Tpo (thyropero-
xidase). Primers were designed based on the Primer Express Program (Applied
Biosystems, Foster City, CA, USA) and SYBRGreen PCR Master Mix (Applied
Biosystems). PCR conditions were optimized for the Gene Amp 5700 Sequence
Detection System (Applied Biosystems). For the purpose of endogenous control,
Rpl19 amplification primers (FWD, 5′-GGCCCGCAAGAAGCTACTG-3′, and
REV, 5′-TTTCGTGCTTCCTTGGTCTTAGA-3′) were used to normalize expres-
sion levels. Quantitative analysis was carried out using the relative standard curve
method to calculate normalized relative expression using the QGENE program
[47]. Each reactionwas performed in triplicate and all experiments were carried out
at least twice. Statistical analyses are presented as means±standard deviation and
were submitted to analysis of variance followed by the Bonferroni t test to compare
results between groups. Differences were considered significant at p≤0.05.Acknowledgments
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